Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Lowers FY '22 PDUFA Fees Due to Hiring, Attrition Concerns
13 Aug 2021
•
By
Derrick Gingery
The agency reissued the user fee notice, saying fewer dollars were needed for new staff.
Despite a more than 2% reduction, the most expensive PDUFA fee still will be more than $3.1m. • Source: Alamy
More from User Fees
More from Pathways & Standards